Clinical trial

SEroma Reduction pOst MAstectomy "SEROMA Study"

NCT03738527

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-10-07

PhasePHASE4

Study timeline

Study start (actual)2019-10-07Date precision: day

Registry last updated2021-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Seroma Complicating A Procedureunresolved

Hematoma Postoperativeunresolved

Breast Cancerunresolved

Interventions

Tranexamic Acid 100mg/mL, 20mL topicalDRUG

Normal Saline Flush, 0.9%, 20mL topicalDRUG

Sponsors & collaborators

Hamilton Health Sciences Corporationlead sponsor

Mapped research locations

HamiltonOntario, Canada2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03738527 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.